materialise innovators you can count on Q3 2024 Financial Results Conference call | October 24, 2024 www.materialise.com | NASDAQ: MTLS Safe Harbor Summary This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our intentions, beliefs, assumptions, projections, outlook, analyses or current expectations, plans, objectives, strategies an ...

Exhibit 99.1 Revenue from our Materialise Software segment increased by 2.8% to 11,111 kEUR for the third quarter of 2024 compared to 10,811 kEUR for the same quarter last year. Segment Adjusted EBITDA increased by 10.9% to 1,975 kEUR from 1,781 kEUR while the segment Adjusted EBITDA margin was 17.8% compared to 16.5% for the corresponding prior-year period. Revenue from our Materialise Manufacturing segment increased by 9.1% to 27,344 kEUR for the third quarter of 2024 compared to 25,056 kEUR for the third ...

vm/E+ via Getty Images The last time I wrote about Materialise NV (NASDAQ:MTLS), I suggested that macro headwinds and ongoing investments would probably limit near-term upside, despite the company's favorable valuation. The stock is now up over 20% since then on the back of stronger-than-expected Q2 results. Growth investments and the transition to a cloud-based software business continue to weigh on margins and growth, but Materialise's business appears to be turning the corner. Headwinds should ease over ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors use fundamental analysis and traditional valuation metrics to fi ...

LEUVEN, Belgium, May 22, 2024 (GLOBE NEWSWIRE) -- Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and sophisticated 3D printing solutions, today announced that it will host its Annual General Shareholders' Meeting at 10:00 am CEST on Tuesday, June 4, 2024. The convening notices and other documents pertaining to the Annual General Shareholders' Meeting, including the annual report, are available on Materialise's website at https://investors.materialise.com/governance- docu ...

LEUVEN, Belgium, May 22, 2024 (GLOBE NEWSWIRE) -- Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and sophisticated 3D printing solutions, today announced that it will host its Annual General Shareholders' Meeting at 10:00 am CEST on Tuesday, June 4, 2024. The convening notices and other documents pertaining to the Annual General Shareholders' Meeting, including the annual report, are available on Materialise's website at https://investors.materialise.com/governance- docu ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE AC ...

materialise innovators you can count on www.materialise.com NASDAQ: MTLS This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our intentions, beliefs, assumptions, projections, outlook, analyses or current expectations, plans, objectives, strategies and prospects, both financial and business, including statements concerning, among ot ...

Financial Data and Key Metrics Changes - Revenue increased by 3.2% to €60.1 million compared to the third quarter of 2022, despite unfavorable market conditions [7][31] - Adjusted EBITDA grew to €7.9 million, representing an increase of almost 55% from €5.1 million last year, with an adjusted EBITDA margin of 13.1% [8][32] - Net profit for the quarter increased to €4 million or €0.07 per share, compared to €1.4 million or €0.02 per share last year [37] Business Line Data and Key Metrics Changes - The manufacturing segment revenue decreased by 4% to €25.1 million, while the software segment remained stable at €10.8 million [7][36] - The medical segment continued its double-digit growth, increasing by 13%, with software revenue growing by 10% and medical device business expanding by 15% [9][36] - Adjusted EBITDA for the medical segment amounted to €7.1 million, resulting in an improved adjusted EBITDA margin of 29.4% [9] Market Data and Key Metrics Changes - The medical segment accounted for 40% of total revenue, while manufacturing and software segments accounted for 42% and 18% respectively [34] - Deferred revenue from software licenses and maintenance fees was €40.1 million, a decrease of €2.7 million compared to the end of 2022, but an increase of €1.7 million compared to September of last year [34] Company Strategy and Development Direction - The company is focused on embracing change while preserving its core mission and values, particularly in the context of 3D printing technology [13][14] - Materialise aims to enhance its digital backbone for additive manufacturing processes, which is crucial for scaling operations [15][16] - The transition in top management is expected to provide continuity and maintain the company's strategic positioning [18][19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate challenging macroeconomic conditions while maintaining revenue guidance for the full year between €255 million and €260 million [47] - The company anticipates that the medical device industry will recover, which could positively impact growth in software activities [64] Other Important Information - The company reported a strong balance sheet with cash reserves of €134 million and a net cash position of €67.7 million [11] - Capital expenditures for the quarter amounted to €3.9 million, including investments in a new metal printing facility in the U.S. [38] Q&A Session Summary Question: Are there any other markets showing increasing interest in the medical segment? - The software revenue is now approximately 30% nonrecurring, with the recurring part representing about 70% and gradually increasing [25] Question: What trends are being seen in the medical device market? - There is robust demand for personalized instruments and guides, but the medical device industry is cautious in its investments due to the current economic situation [64] Question: Can you provide an update on deferred revenues? - Deferred revenue has decreased in recent quarters due to timing effects, but it is expected to pick up again in the fourth quarter based on historical trends [54][55]

9 | --- | --- | --- | --- | |---------------------------|-------------------------------------------------|----------|----------| | | (in thousands of euros, except where indicated) | Q3 2023 | Q3 2022 | | Revenue | | 60,130 | 58,288 | | Cost of sales | | (26,435) | (26,245) | | Gross profit | | 33,696 | 32,042 | | | Research & development expenses | (9,476) | (9,313) | | | Sales & marketing expenses | (13,960) | (15,198) | | | General & administrative expenses | (8,640) | (8,980) | | | Other income/(expens ...